Dolly Khannas Portfolio Gains 8 in First Half of 2026 Led by Five Stocks Rising Up to 26 Unexpected Housing Market Development Puts American Homeowners and Buyers at a Crossroads Healthcare and Tech Lead SP 500 to Modest Gains as Communication Services Lags Shein Acquires Everlane A New Chapter for Ethical Fast Fashion AI Semiconductor Futures Set to Launch on CME Groups Compute Market One House Three Owners How the American Dream of Homeownership Is Becoming Pricier WALD Q4 2024 Earnings EPS Misses Estimates as Losses Widen FGBIP Q1 2026 Earnings Earnings Beat Estimates by Wide Margin Stock Nearly Flat Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines Valmont Industries VMI Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Strength Rail Vision Ltd RVSN Q3 2023 Earnings EPS Surprises to the Upside Despite Narrowing Losses WPC Q1 2026 Earnings EPS Surges 1822 Above Estimates Defying Market Expectations Meiwu Technology WNW Slips 39 as Support Levels Come into Focus Vail Resorts MTN Exhibits Strength as Shares Rebound 358 Solaris Resources SLSR Surges 5 Momentum Builds Above Key Support JDcom Edges Higher as Resistance Test Looms BlackRock Science and Technology Trust BST Advances 155 as Growth Stocks Find Favor EMCOR Group Q1 2026 Earnings EPS Soars Past Estimates as Operational Efficiency Drives Strong Beat IBKR Q1 2026 Earnings EPS Misses Estimates by 22 Stock Falls Slightly CRWD Q1 2026 Earnings EPS Slightly Misses Estimates Stock Drops 39 vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue CANF Q4 2023 Earnings NarrowerthanExpected Loss Signals Operational Progress KOD Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips Beyond Inc to Acquire Buy Buy Baby Brand Rights Reunite with Bed Bath Beyond LOVE Q1 2026 Earnings EPS Beats Estimates by 682 Commercial Bancgroup Inc CBK Edges Higher on Moderate Volume Testing Key Resistance SLSN Q1 2026 Earnings Loss Per Share of 001 as Shares Decline 234 Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings EPS Misses Estimates Amid Pipeline Progress Stock Rises 308 PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline REZI Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges PFG Q1 2026 Earnings EPS Beat Amid Modest Share Decline DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss